Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  MEDNAX, Inc.    MD

MEDNAX, INC.

(MD)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector news

Mednax : Shares Down 10% After 4Q Earnings Miss, Contract Cancellations

share with twitter share with LinkedIn share with facebook
share via e-mail
02/20/2020 | 09:05am EDT

By Chris Wack

 

Mednax Inc. shares were down 10% to $24 premarket after the company had contracts cancelled by affiliates of UnitedHealth and it reported earnings that missed analysts' expectations.

The company reported fourth-quarter earnings of $9.3 million, or 11 cents a share, compared with $60.2 million, or 68 cents a share, in the same period a year ago. Analysts polled by FactSet were looking for earnings of $41.3 million, or 59 cents a share.

Revenue for the quarter was $905.4 million, compared with last year's $888.4 million and the $901.2 million analysts were expecting.

Mednax also said it has received notification by entities affiliated with UnitedHealth Group that contracts of the company's affiliated practices across four states, covering all of the services that Mednax-affiliated physicians provide in those states, have been unilaterally terminated, with effective dates ranging from March 1 to Sept. 1, 2020.

Mednax said the total annual historical revenue under these contracts represents about 2% of its consolidated annual 2019 revenue of $3.5 billion.

Mednax said that given the unprecedented nature of these actions, it can't estimate the impact of these surprise terminations, which eliminate from United's networks Mednax-affiliated physicians providing anesthesia coverage, neonatology and high-risk obstetrics in urban and rural areas.

 

Write to Chris Wack at chris.wack@wsj.com

 

Stocks mentioned in the article
ChangeLast1st jan.
MEDNAX, INC. -7.56% 10.83 Delayed Quote.-58.11%
UNITEDHEALTH GROUP -4.60% 237.94 Delayed Quote.-15.17%
share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on MEDNAX, INC.
03/25MEDNAX, INC. : Creation of a Direct Financial Obligation or an Obligation under ..
AQ
03/25MEDNAX : Provides COVID-19-Related Business Update
BU
03/12MEDNAX : Obstetrix Medical Group Launches HRO Program for Labor & Delivery
BU
02/20MEDNAX : Shares Down on Cancelled Contracts, 4Q Earnings Miss
DJ
02/20MEDNAX : Shares Down 10% After 4Q Earnings Miss, Contract Cancellations
DJ
02/20MEDNAX, INC. : Results of Operations and Financial Condition (form 8-K)
AQ
02/20MEDNAX : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS..
AQ
02/20MEDNAX : 4Q Earnings Snapshot
AQ
02/20MEDNAX : Reports Fourth Quarter Results
BU
02/14New Zealand Extends Ban on Foreigners Traveling from China
DJ
More news
Financials (USD)
Sales 2020 3 509 M
EBIT 2020 335 M
Net income 2020 128 M
Debt 2020 1 438 M
Yield 2020 -
P/E ratio 2020 7,74x
P/E ratio 2021 5,72x
EV / Sales2020 0,68x
EV / Sales2021 0,68x
Capitalization 961 M
Chart MEDNAX, INC.
Duration : Period :
MEDNAX, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MEDNAX, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Average target price 19,08  $
Last Close Price 11,64  $
Spread / Highest target 106%
Spread / Average Target 63,9%
Spread / Lowest Target -39,9%
EPS Revisions
Managers
NameTitle
Roger J. Medel Chief Executive Officer & Director
Cesar L. Alvarez Chairman
Stephen D. Farber Chief Financial Officer & Executive Vice President
Tony Ambegaoker Chief Information Officer
Waldemar A. Carlo Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
MEDNAX, INC.-58.11%961
CVS HEALTH CORPORATION-20.14%77 376
HCA HEALTHCARE, INC.-39.21%30 411
FRESENIUS MEDICAL CARE AG & CO. KGAA-8.73%19 486
LABORATORY CORPORATION OF AMERICA HOLDINGS-25.29%12 298
QUEST DIAGNOSTICS-24.81%10 716